Keisuke Miyazawa

Professor and Chairman

Tokyo Medical and Dental University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Keisuke Miyazawa is a Professor and Chairman at Tokyo Medical University in Japan. His research primarily focuses on autophagy, lysosomal dynamics, and the therapeutic effects of macrolide antibiotics in cancer treatment. Recent articles highlight his work on the cytotoxic mechanisms of drugs like azithromycin and their interactions with cytoskeletal protein dynamics and organelle dysfunctions in various cancer types.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Hirotsugu Hino

Assistant Professor

Nihon University School of Medicine

JAPAN

View details

Naoharu Takano

Tokyo Medical and Dental University

JAPAN

View details

MASAKI HIRAMOTO

Associate Professor

Tokyo Medical and Dental University

JAPAN

View details

Masahiko Kuroda

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Keisuke Miyazawa

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics

p53 regulates lysosomal membrane permeabilization as well as cytoprotective autophagy in response to DNA-damaging drugs

Ricolinostat enhances adavosertib‑induced mitotic catastrophe in TP53‑mutated head and neck squamous cell carcinoma cells.

Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.

Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics.

Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells

BRCA1 degradation in response to mitochondrial damage in breast cancer cells.

Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization‑associated cell death.

Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin

Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes

Collaborators (4)

Hirotsugu Hino

Naoharu Takano

MASAKI HIRAMOTO

Masahiko Kuroda

Make your next move.